Which management approach is most appropriate for immunocompromised patients with suspected respiratory infection?

• A. Use narrow empiric coverage and no diagnostics
• B. Rely on symptoms alone
• C. Delay antibiotics until cultures are positive
• D. Use broader empiric coverage and aggressive diagnostics

Answer: (D)

In immunocompromised patients, infections can progress quickly and present atypically, so you need timely, broad empiric therapy paired with an aggressive diagnostic workup. Starting broad coverage right away helps address a wide range of potential pathogens—bacteria (including gram-negatives and resistant organisms), fungi, and sometimes viruses—before the exact cause is known. At the same time, you pursue rapid diagnostics: blood and respiratory cultures, chest imaging, viral panels, fungal testing, and, if needed, bronchoscopy with lavage. This approach allows you to tailor therapy sooner and avoid missing less common or opportunistic organisms. Relying on symptoms alone isn’t reliable in this population, since fever or typical signs may be blunted, and delaying antibiotics until cultures are positive can lead to deterioration and higher mortality.